Cambridge Healthcare Research, a Cambridge-based life sciences and healthcare consultancy, has named Stella Wooder as strategic adviser, it was reported yesterday.
Wooder has more than 25 years of experience of healthcare and technology consulting and she currently chairs the board of trustees at Team – which works with many large pharmaceutical and medical device companies to design and develop medical devices – after spending time delivering client projects at the consultancy through a significant phase of growth. She is also a non-executive director of Gynii Me – an early-stage company in the fertility treatment sector – and is an honorary lecturer at the Institute of Biotechnology at the University of Cambridge. Wooder's career has also included the role of operations director at science, technology and product development company Sagentia – where she worked for more than a decade – as well as time at life sciences consultancy, Pope Woodhead & Associates.
Edward Cartwright, a partner at CHR, said, 'We are delighted to welcome Stella to the team as we begin this new chapter in our growing success story. Her expertise in building successful healthcare consulting firms will be invaluable as we expand our global business to help even more healthcare clients, as well as product and brand teams, make sense of their rapidly evolving markets and inform their winning strategy.'
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign
Physiomics expands into biometrics with two contract wins and new division head